ETERNA THERAPEUTICS INC (ERNA)

US1140822099 - Common Stock

0.3298  -0.01 (-4.13%)

Premarket: 0.33 +0 (+0.06%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth

-100.00%		68K
EBITDA
YoY % growth
-27.31M
-646.17%		-27.07M
0.88%		-20.591M
23.93%
EBIT
YoY % growth
-27.43M
-407.96%		-27.23M
0.73%		-20.675M
24.07%
Operating Margin
N/AN/A-30,404.41%
EPS
YoY % growth
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -1.03
58.63%		%
Q3 2022
Q2Q % growth		 -2.49
-13.18%		-2.24-0.25-10.96%
Q2 2022
Q2Q % growth		 -1.20 -2.651.4554.75%
Q1 2022
Q2Q % growth		 -3.40 -2.86-0.54-19.05%
Q4 2021
Q2Q % growth		 -3.20 -2.55-0.65-25.49%
Q3 2021
Q2Q % growth		 -2.20 -1.63-0.57-34.80%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 487K
874.00%		%
Q4 2021
Q2Q % growth
-100.00%		%
Q3 2021
Q2Q % growth
-100.00%		%
Q2 2021
Q2Q % growth
-100.00%		%
Q1 2021
Q2Q % growth
-100.00%		%
Q4 2020
Q2Q % growth		 1.18M
-77.18%		%
Q3 2020
Q2Q % growth		 1.48M
-67.69%		%
Q2 2020
Q2Q % growth		 750K
-85.66%		%
Q1 2020
Q2Q % growth		 2.39M
-50.52%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A